Head and neck cancer-Part 1: Epidemiology, presentation, and preservation

Clinical Otolaryngology

Volumn 36, Issue 1, 2011, Pages 65-68

  Mehanna, H ^a   Paleri, V ^b   West, C M L ^c   Nutting, C ^d  

^a UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; HERPES SIMPLEX VACCINE; VIRUS DNA;

ALCOHOL ABUSE; ASPIRATION BIOPSY; BODY MASS; CANCER IMMUNIZATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIETARY INTAKE; DISTANT METASTASIS; ECHOGRAPHY; EPSTEIN BARR VIRUS INFECTION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HEAD AND NECK CARCINOMA; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; MOUTH CARCINOMA; MOUTH HYGIENE; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL EXPOSURE; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SENTINEL LYMPH NODE BIOPSY; SEX DIFFERENCE; SEX RATIO; SEXUAL BEHAVIOR; SMOKING; SMOKING CESSATION; SQUAMOUS CELL CARCINOMA; SYMPTOMATOLOGY;

AGE DISTRIBUTION; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; HEAD AND NECK NEOPLASMS; HUMANS; MORBIDITY; NEOPLASM STAGING; RISK FACTORS; WORLD HEALTH;

EID: 79952763302     PISSN: 17494478     EISSN: 17494486     Source Type: Journal    
DOI: 10.1111/j.1749-4486.2010.02231.x     Document Type: Review

References (21)

1. WHO. Theglobal burden of disease: 2004 update. 2008. www.who.int/evidence/bod.
2. Boyle P, Levin B.eds. World cancerreport. InternationalAgencyfor Research on Cancer, 2008.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoSMed 2006;3:e442.
4. Mehanna H,Jones TM,Gregoire V,Ang KK.Oropharyngealcarcinoma related to human papillomavirus. BM] 2010;340:d439.
5. Oxford Cancer Intelligence Unit. Profile of head and neck cancers in England. 2010. http://library.ncin.onj.uk/docs/100504-0CIU-Head_and_Neck_Prafiles.pdf.
6. Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic ofviral-induced carcinoma? Int] Cancer 2009:125:362-6.
7. Conway Dl, HashibeM, Boffetta P,Wunsch-FilhoV, MuscatJ, LaVecchia C, et al. Enhancingepidemiologic research on head and neck cancer: INHANCE-the International Head and Neck Cancer Epidemiology Consortium. Oral Oncol 2009:45:743-6.
8. Purdue MP, Hashibe M, BerthillerJ, La Vecchia C, DalMaso L, Herrero R, et al Type of alcoholic beverage and riskof head and neckcancer-a pooled analysis withinthe INHANCE Consortium./lmyFpWemfo/2009;169:-132-42.
9. Hashibe M, Brennan P, Benhamou S, CastellsagueX, Chen C, Curado MP, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the riskof head and neckcancer: pooled analysis in the International Head and NeckCancer Epidemiology Consortium./Nat/Cancer Inst 2007:99:777-89.
10. WHO. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 90-human papillomavi ruses. Intemational Agency for Research on Cancer, 2007. http://monographs.iarc.fr/ENG/Monographs/vol90/index.php.
11. HeckJE, BerthillerJ, VaccarellaS,Winn DM.Smith EM,Shan'ginaO,et al. Sexual behaviours and the riskof head and neckcancers: a pooled analysis in the International Head and NeckCancer Epidemiology (INHANCE) Consortium./nt; fp/dem/o/ 2010:39:166-81.
12. NationallnstituteforHealthandClinicalExcellence. Improvingoutcomes in head and neckcancers-the manual. 2004. http://guidance.nice.onj. uk/csghn/guidance/pdf/English.
13. Paleri V, Staines K, Sloan P, Douglas A, Wilson j. Evaluation of oral ulceration in primary care. SW2010;340:c2639.
14. Van den Brekel MW, CastelijnsJA, Stel HV, Golding RP, Meyer Cj, SnowGB. Modem imagingtechniquesand ultrasound-guided aspiration cytology fbrthe assessment of necknode metastases: a prospective comparative study.fuMrc/?OtorWnofar)mgo(1993;250:ll-7.
15. Isles MG. McConkey C Mehanna HM. Asystematicreviewandmeta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. din Otalaryngol 2008:33:210-22.
16. Singhi AD, WestraWH. Comparison of human papillomavirus in situ hybridization and pl6 immunohistochemistry in the detection of human papillomavirus-associated head and neckcancer based on a prospective clinicalexperience. Cancer 2010;116:2166-73.
17. Kujan 0, Glenny AM, Oliver RJ, Thakker N, Sloan P. Screening programmes forthe early detection and prevention of oral cancer. Cochrane Database SjoWe/2006;3:CD004150.
18. Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R,Thara S, Math ewB, et al; forthe Trivandrum Oral CancerScreening Study Group. Effect of screeningon oralcancermortality in Kerala, India: a cluster-randomised controlled trial. Lancet 2005:365:1927-33.
19. Fanconi Anaemia Clinical Network. Clinical standardsof care in the UK. www.fanconi.org.uk/clinical-network/standards-of-care/.
20. Marron M, Boffetta P, ZhangZF, Zaridze D, Wiinsch-Filho V, Winn DM, et al. Cessation of alcohol drinking, tobacco smoking and the reversal of head and neckcancer risk. Intl Epidemiol 2010;39:182-96.
21. Kim JJ.Goldie SJ. Costeffectivenessanalysisofincludingboysina human papillomavirus vaccination programme in the United States. BM] 2009;339:b3884.